Richarf
0009-0000-3657-6229
1 paper found
Refreshing results…
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Missing publications? Search for publications with a matching author name.